Obama Signs Generic, Biosimilar User Fee Programs Into Law
President Barack Obama signed a bill that creates new user fee programs for generic drugs and biosimilars into law now giving the FDA almost three months to before fully launching the programs.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.